INSTITUTION

GSK Investigational Site, Daytona Beach, Florida VIIV Healthcare – Study Sponsor A single dose escalation study to determine the safety, tolerability, and pharmacokinetic profile of intramuscular and subcutaneous injections of GSK1265744 long acting parenteral (LAP) in healthy subjects. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download